Talk:Viceroy Research

Adding ticker templates to list of reports?
Wouldn't it be a great idea if we used the ticker templates for the tickers in the list? That would also standardize the convention around them. Now it is~mostly Bloomberg ticker? Category:Ticker_symbol_templates --Orubblig (talk) 17:44, 27 August 2023 (UTC)

This is the account of Viceroy Research. This page appears to be maliciously edited with several inaccuracies. 1.	Viceroy Research is engaged in litigation with Medical Properties Trust. 2.	Adler Group did not sue Viceroy Research and nothing in the referenced article states this. The article only states that Caner filed a lawsuit against Perring and Viceroy. Viceroy never agreed to pay Adler any sum. 3.	GNC holdings has never sued Viceroy Research. There is no reference for this information. 4.	The UK Financial Conduct Authority has never fined Viceroy Research. There is no reference for this information. 5.	The UK Financial Conduct Authority did not open “questions into Viceroy Research's relationship with Cayman Island hedge fund Oasis Management”. This was done by Home REIT, a company whose internal investigation found “undeclared potential conflicts of interest” and “lack of transparency”. There is no mention in the referenced article of the FCA. 6.	The US SEC has never charged Viceroy Research with “making false and misleading statements in a research report about the company Sino Biopharmaceutical”. Viceroy has never published a report on Sino Biopharmaceutical. There is no reference for this information. 7.	BaFin has never fined Viceroy Research regarding its work into Grenke. There is no reference for this information. 8.	The fine imposed by the FSCA on Viceroy Research was set aside by the Financial Services Tribunal https://www.iol.co.za/business-report/companies/viceroys-r50m-capitec-fine-set-aside-by-tribunal-82454ab0-690e-4ac5-8fab-d9f9814d8520 — Preceding unsigned comment added by ViceroyResearch (talk • contribs) 13:50, 20 November 2023 (UTC)